Filing Details
- Accession Number:
- 0000950170-25-078982
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-29 16:17:48
- Reporting Period:
- 2025-05-28
- Filing Date:
- 2025-05-29
- Accepted Time:
- 2025-05-29 16:17:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1880438 | An2 Therapeutics Inc. | ANTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1873879 | M Margaret Fitzpatrick | C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027 | No | No | No | No |
Transaction Summary
Purchased: | 8,610 shares | Avg. Price: $1.18 | Total Value: $10,133.11 |
Number of Shares After Transactions: | 8,610 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-28 | 8,610 | $1.18 | 8,610 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.